These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 1847638)

  • 1. Temperature dependence of [3H]PAF binding to washed human platelets.
    Borea PA; Montesi L; Muzzolini A; Fantozzi R
    Biochem Pharmacol; 1991 Feb; 41(4):629-30. PubMed ID: 1847638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional validation of platelet-activating factor receptor sites characterized biochemically by a specific and reproducible [3H]platelet-activating factor binding in human platelets.
    Tahraoui L; Floch A; Cavero I
    J Pharmacol Exp Ther; 1990 Mar; 252(3):1221-7. PubMed ID: 2156995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PAF binding sites. Characterization by [3H]52770 RP, a pyrrolo[1,2-c]thiazole derivative, in rabbit platelets.
    Robaut C; Durand G; James C; Lave D; Sedivy P; Floch A; Mondot S; Pacot D; Cavero I; Le Fur G
    Biochem Pharmacol; 1987 Oct; 36(19):3221-9. PubMed ID: 2822048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High affinity specific binding sites for tritiated platelet-activating factor in canine platelet membranes: counterparts of platelet-activating factor receptors mediating platelet aggregation.
    Tahraoui L; Floch A; Mondot S; Cavero I
    Mol Pharmacol; 1988 Aug; 34(2):145-51. PubMed ID: 2842653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding and metabolism of platelet-activating factor by human neutrophils.
    O'Flaherty JT; Surles JR; Redman J; Jacobson D; Piantadosi C; Wykle RL
    J Clin Invest; 1986 Aug; 78(2):381-8. PubMed ID: 3016027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Response to platelet-activating factor in human platelets stored and aged in plasma. Decrease in aggregation, phosphoinositide turnover, and receptor affinity.
    Shukla SD; Morrison WJ; Klachko DM
    Transfusion; 1989; 29(6):528-33. PubMed ID: 2546298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of platelet agonists on the binding of platelet-activating factor to human platelets.
    Burgers JA; Akkerman JW
    J Lipid Mediat; 1992 Sep; 5(3):289-300. PubMed ID: 1334723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding of [3H]SR 27417, a novel platelet-activating factor (PAF) receptor antagonist, to rabbit and human platelets and polymorphonuclear leukocytes.
    Herbert JM; Laplace MC; Maffrand JP
    Biochem Pharmacol; 1993 Jan; 45(1):51-8. PubMed ID: 8381007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Occupancy of platelet receptors for platelet-activating factor in patients with septicemia.
    Lopez Diez F; Nieto ML; Fernandez-Gallardo S; Gijon MA; Sanchez Crespo M
    J Clin Invest; 1989 May; 83(5):1733-40. PubMed ID: 2540221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipoprotein-associated paf (LA-paf) was found in washed human platelets and monocyte/macrophage-like U937 cells.
    Korth R; Zimmermann K; Richter WO
    Chem Phys Lipids; 1994 Apr; 70(2):109-19. PubMed ID: 8033283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition by CV-3988 of the binding of [3H]-platelet activating factor (PAF) to the platelet.
    Terashita Z; Imura Y; Nishikawa K
    Biochem Pharmacol; 1985 May; 34(9):1491-5. PubMed ID: 2986648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sheep platelets as a model for human platelets: evidence for specific PAF (platelet activating factor) receptors.
    Slattery CW; Beaumont DO
    Thromb Res; 1989 Sep; 55(5):569-76. PubMed ID: 2554526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of SR 27417 on the binding of [3H]PAF to rabbit and human platelets and human polymorphonuclear leukocytes.
    Herbert JM; Laplace MC; Cailleau C; Maffrand JP
    J Lipid Mediat; 1993 May; 7(1):57-78. PubMed ID: 8395255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. L-659,989: a useful probe in the detection of multiple conformational states of PAF receptors.
    Hwang SB; Lam MH
    Lipids; 1991 Dec; 26(12):1148-53. PubMed ID: 1668109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of platelet-activating factor (PAF) receptor by specific binding of [3H]L-659,989, a PAF receptor antagonist, to rabbit platelet membranes: possible multiple conformational states of a single type of PAF receptors.
    Hwang SB; Lam MH; Hsu AH
    Mol Pharmacol; 1989 Jan; 35(1):48-58. PubMed ID: 2536468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of sulfhydryl reagents on PAF binding to human neutrophils and platelets.
    Ng DS; Wong K
    Eur J Pharmacol; 1988 Sep; 154(1):47-52. PubMed ID: 2846326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuous binding of the PAF molecule to its receptor is necessary for the long-term aggregation of platelets.
    Suzuki M; Sugatani J; Ino M; Shimura M; Akiyama M; Yamazaki R; Suzuki Y; Miwa M
    Am J Physiol; 1998 Jan; 274(1):C47-57. PubMed ID: 9458712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radioligand competitive binding methodology for the evaluation of platelet-activating factor (PAF) and PAF-receptor antagonism using intact canine platelets.
    Janero DR; Burghardt B; Burghardt C
    J Pharmacol Methods; 1988 Nov; 20(3):237-53. PubMed ID: 2853256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solubilization of a functionally active platelet-activating factor receptor from rabbit platelets.
    Rogers JE; Duronio V; Wong SI; McNeil M; Salari H
    Biochem J; 1991 Sep; 278 ( Pt 2)(Pt 2):405-10. PubMed ID: 1654881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Species-dependent differences of high affinity [3H]PAF-binding to platelets from humans and pigs and its inhibition by selected antagonists.
    Ostermann G; Lorenz A; Hofmann B; Kertscher HP
    J Lipid Mediat; 1991 Nov; 4(3):289-98. PubMed ID: 1662546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.